Construction and in vivo efficacy of a replication-deficient recombinant adenovirus encoding murine growth hormone

Endocrinology

Volumn 140, Issue 1, 1999, Pages 260-265

  Marmary, Yitzhak ^a   Parlow, Albert F ^b   Goldsmith, Corinne M ^a   He, Xinjun ^a   Wellner, Robert B ^a   Satomura, Kazuhito ^c   Kriete, Martin F ^c   Robey, Pamela Gehron ^c   Nieman, Lynnette K ^d   Baum, Bruce J ^a,e  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c Gene Therapy and Therapeutics Branch   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GROWTH HORMONE; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GENE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; VIRUS RECOMBINANT;

EID: 0032894645     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.1.6400     Document Type: Article

References (28)

1. 1. Bailey JE 1991 Towards a science of metabolic engineering. Science 252:1668-1675
2. 2. Tripathy SK, Svensson EC, Black HB, Goldwasser E, Margalith M, Hobart PM, Leiden JM 1996 Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc Natl Acad Sci USA 93:10876-10880
3. 3. Mulligan RC 1993 The basic science of gene therapy. Science 260:926-932
4. 4. Verma IM, Somia N 1997 Gene therapy-promises, problems and prospects. Nature 389:239-242
5. 3. Kay MA, Lui D, Hoogerbrugge PM 1997 Gene therapy. Proc Natl Acad Sci USA 94:12744-12746
6. 6. Crystal RG 1995 The gene as the drug. Nature Med 1:15-17
7. 7. Tripathy SK, Black HB, Goldwasser E, Leiden JM 1996 Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med 2:545-550
8. 8. Svensson EC, Black HB, Dugger DL, Tripathy SK, Goldwasser E, Hao Z, Chu L, Leiden JM 1997 Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum Gene Ther 8:1797-1806
9. 9. Kagami H, O'Connell BC, Baum BJ 1996 Evidence for the systemic delivery of a transgene product from salivary glands. Hum Gene Ther 7:2177-2184
10. 10. He X, Goldsmith CM, Marmary Y, Wellner RB, Parlow AF, Nieman LK, Baum BJ 1998 Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands. Gene Ther 5:537-541
11. 11. Sinha YN, Salocks CB, Vanderlaan WP 1975 Pituitary and serum concentrations of PRL and GH in Snell dwarf mice. Proc Soc Exp Biol Med 150:207-210
12. 12. Bates PC, Holder AT 1988 The anabolic actions of growth hormone and thyroxine on protein metabolism in Snell dwarf and normal mice. J Endocrinol 119:31-41
13. 13. Al-Hendy A, Hortelano G, Tannenbaum GS, Chang PL 1995 Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts - an alternate approach to somatic gene therapy. Hum Gene Ther 6:165-175
14. 14. Delporte C, O'Connell BC, He X, Lancaster HE, O'Connell AC, Agre P, Baum BC 1997 Increased fluid secretion after adenoviral-mediated transfer of aquaporin-1 cDNA to irradiated rat salivary glands. Proc Natl Acad Sci USA 94:3268-3273
15. 15. He X, Frank DP, Tabak LA 1990 Establishment and characterization of 12S adenoviral E1A immortalized rat submandibular gland epithelial cells. Biochem Biophys Res Commun 170:336-343
16. 16. Adesanya M, Redman RS, Baum BJ, O'Connell BC 1996 Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands. Hum Gene Ther 7:1085-1093
17. 17. Huard J, Lochmuler H, Ascadi G, Jani A, Massie B, Karpati G 1995 The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 2:107-115
18. 18. Van Buul-Offers S, Smeats T, Van den Brande JL 1984 Effects of growth hormone and thyroxine on the relation between tibial length and the histological appearance of the proximal tibial epiphysis in Snell dwarf mice. Growth 48:166-175
19. 19. Mastrangeli A, O'Connell B, Aladib W, Fox PC, Baum BJ, Crystal RG 1994 Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am J Physiol 266:G1146-G1155
20. 20. Goldfine ID, German MS, Tseng H-C, Wang J, Bolaffi J, Chen J-W, Olson DC, Rothman SS 1997 The endocrine secretion of human insulin and growth hormone by exocrine glands of the gastrointestinal tract. Nat Biotechnol 15:1378-1382
21. 21. Svensson EC, Tripathy SK, Leiden JM 1996 Muscle-based gene therapy: realistic possibilities for the future. Mol Med Today 2:166-172
22. 22. Connelly S, Gardner JM, McClelland A, Kaleko M 1996 High-level tissue-specific expression of functional human factor VIII in mice. Hum Gene Ther 7:183-195
23. 23. Walter J, You Q, Hagstrom JN, Sands M, High KA 1996 Successful expression of human factor IX following repeat administration of an adenoviral vector in mice. Proc Natl Acad Sci USA 93:3056-3061
24. 24. Michou AI, Santoro L, Christ M, Julliard V, Pavirini A, Mehtali M 1997 Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther 4:473-482
25. 25. Corpas E, Harman SM, Blackman MR 1993 Human growth hormone and human aging. Endocr Rev 14:20-39
26. 26. Jorgenson JOL, Muller J, Moller J, Wolthers T, Vahl N, Juul A, Skakkebak NE, Christiansen JS 1994 Adult growth hormone deficiency. Horm Res 42:235-241
27. 27. Sacca L, Fazio S 1996 Cardiac performance: growth hormone enters the race. Nat Med 2:29-30
28. 28. Shalet SM 1996 Growth hormone deficiency and replacement in adults. Br Med J 313:314